Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Tocilizumab (TCZ) is a humanized monoclonal antibody targeting the receptor for IL
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Tocilizumab (TCZ) is a humanized monoclonal antibody targeting the receptor for IL
Tocilizumab (TCZ) is a humanized monoclonal antibody against the IL‑6 receptor
Almudena Nuno-Gonzalez, Jose Luis Lopez Estebaranz, Jose Antonio Rueda Orgaz, Mercedes Mitjavila, Fernando Pinedo-Moraleda and Francisco Javier Vicente-Martin PDF Share this article
For authors and organisers
Find the right journal for your paper and submit your manuscript.